Apr 26, 2023
158:157
For every 157 shares held, investors received 158. The price per share adjusted from $26.55 to $26.38.
The split itself did not change the total investment value.
Merdury Biopharmaceutical Corporation (TPEX:6932) operates in the Pharmaceuticals: major industry.
Merdury Biopharmaceutical Corporation company overviewMerdury Biopharmaceutical Corporation's most recent stock split was on April 26, 2023. It was a 158-for-157 forward split, so shareholders received 158 shares for every 157 they held.
Merdury Biopharmaceutical Corporation has split its stock once. This history records one forward split, on April 26, 2023.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Merdury Biopharmaceutical Corporation's 158-for-157 split on April 26, 2023, every 157 shares became 158 shares.
Merdury Biopharmaceutical Corporation has not announced a new split in our records. Its most recent split was on April 26, 2023, 3 years ago. Companies announce splits in advance, and any new TPEX:6932 split will appear on this page.
Already premium?